Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

This secondary analysis of the Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction clinical trial evaluates clinical characteristics, outcomes, and treatment response to vericiguat according to prespecified index event subgroups and time from index heart failure hospitalization.